Bladder Cancer,Genitourinary Cancer Nivolumab in Adjuvant Urothelial Carcinoma: Survival Benefit Apr 16, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) CTX130 Demonstrates Durable Complete Response in RCC Study Apr 12, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Impact of CD3+ & CD8+ T Cells on ccRCC Survival Apr 09, 2024
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Galectin-1: Predictor of Therapeutic Response in RCC Apr 03, 2024
Bladder Cancer,Genitourinary Cancer Examination of Psoriasis & Bladder Cancer: MR Analysis Apr 03, 2024
Bladder Cancer,Genitourinary Cancer uMRD Predicts NIMBC Recurrence & Nadofaragene Response Apr 01, 2024
Bladder Cancer,Genitourinary Cancer Neoadjuvant Nivolumab + Ipilimumab in UTUC: Updated Results Mar 28, 2024
Bladder Cancer,Genitourinary Cancer Gemcitabine/Cisplatin ± Berzosertib in mUC: Extended Follow-up Mar 26, 2024
